News
IINN
2.300
-0.43%
-0.010
Weekly Report: what happened at IINN last week (0506-0510)?
Weekly Report · 5d ago
Inspira Technologies files to sell 4.42M ordinary shares for holders
Inspira Technologies files to sell 4.42M ordinary shares for holders May 09, 2024 5:20 PM ET. Inspira Technologies Oxy B.H.N. Ltd. Filed a prospectus related to the offer and resale by the selling shareholders of 4.41 million ordinary shares.
Seeking Alpha · 05/09 21:20
Weekly Report: what happened at IINN last week (0429-0503)?
Weekly Report · 05/06 10:25
Inspira Technologies Rolls Out Revolutionary Respiratory Device
TipRanks · 05/02 14:57
Inspira Announces Start Of Production Of The INSPIRA ART100 Medical Device
Inspira announces start of production of the INSPIRA ART100 medical device. The first batch of the device will be used for deployment in several initial sites. The device is being manufactured by a leading technology company for the medical, aero-space and aviation industries.
Benzinga · 05/02 13:18
Inspira™ Announces Start of Production of the INSPIRA™ ART100
Barchart · 05/02 08:18
Weekly Report: what happened at IINN last week (0422-0426)?
Weekly Report · 04/29 10:30
Inspira Technologies Achieves CSA Compliance Milestone
TipRanks · 04/25 13:58
Inspira Receives CSA Certification Of Compliance To U.S. Standards For The INSPIRA ART100
Inspira has received the Canadian Standards Association (CSA) Certification of Compliance to U.S. Standards for the INSPIRA ART100 device. The company believes this is an important milestone on the path to market access for the medical device. Inspira is a breakthrough medical technology company.
Benzinga · 04/25 12:04
INSPIRA™ RECEIVES CSA CERTIFICATION OF COMPLIANCE TO U.S. STANDARDS FOR THE INSPIRA™ ART100
Reuters · 04/25 12:00
Weekly Report: what happened at IINN last week (0415-0419)?
Weekly Report · 04/22 10:24
Inspira Technologies Partners with Beilinson for Organ Transplant Tech
TipRanks · 04/17 11:44
Inspira signs collaboration term sheet with the Beilinson Hospital
Healthcare Inspira signs collaboration term sheet with the Beilinson Hospital in Israel for the evaluation of its proprietary INSPIRA ART100 device in organ transplant procedures. The hospital will provide IINN with access to the internally logged data and diagnostics from the use of the device.
Seeking Alpha · 04/16 13:28
INSPIRA TECHNOLOGIES OXY BHN - TERM SHEET WITH BEILINSON HOSPITAL FOR EVALUATION OF PROPRIETARY INSPIRA ART100 DEVICE IN ORGAN TRANSPLANT PROCEDURES
Reuters · 04/16 12:42
INSPIRA™ SIGNS TERM SHEET FOR USE OF INSPIRA™ ART100 DEVICE IN ORGAN TRANSPLANT PROCEDURES
Reuters · 04/16 12:42
Weekly Report: what happened at IINN last week (0408-0412)?
Weekly Report · 04/15 10:18
Inspira Announces Breakthrough Infection Prevention Tech
TipRanks · 04/11 08:41
Inspira Technologies Oxy Bhn Ltd: Report of foreign issuer
Press release · 04/10 14:16
INSPIRA™ AND ENNOCURE IN VITRO STUDY RESULTS SHOW 100% PREVENTION OF BACTERIAL GROWTH THAT CAUSES BLOODSTREAM INFECTIONS
Reuters · 04/10 12:25
Inspira Technologies Shareholders Approve Agenda
TipRanks · 04/09 20:58
More
Webull provides a variety of real-time IINN stock news. You can receive the latest news about Inspira Technologies Oxy Bhn Ltd through multiple platforms. This information may help you make smarter investment decisions.
About IINN
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.